- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS Moves to Streamline Reporting, Update e-Prescribing Requirements
HHS issued final rules to streamline reporting requirements for hospitals and update technical requirements for electronic prescribing that the Obama administration says could save more than $5 billion in federal funding over five years.
Read the full story: http://hcp.lv/Jqs3y3
Source: ModernHealthcare.com
One regulation eliminates outdated hospital management requirements (PDF)—and some reporting rules—in the Medicare Conditions of Participation for those hospitals that treat Medicare and Medicaid patients, which is expected to save about $940 million annually. The other rule applies to providers other than hospitals and includes changes such as updating e-prescribing technical requirements (PDF) so that Medicare prescription drug plans meet today's standards. That regulation is expected to yield more than $200 million in the first year.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Managed Care Reflections: A Q&A With Melinda B. Buntin, PhD
June 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The June issue features a conversation with Melinda B. Buntin, PhD, a health economist and a Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Carey Business School.
Read More
